Theranexus Logo

Theranexus

Clinical-stage biopharmaceutical company developing treatments for rare neurological disorders.

ALTHX | PA

Overview

Corporate Details

ISIN(s):
FR0013286259
LEI:
969500BFCV6IC7MFQP20
Country:
France
Address:
60 AVENUE ROCKEFELLER, 69008 LYON

Description

THX Pharma (formerly Theranexus) is an innovative, clinical-stage biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company specializes in developing treatments for rare neurological disorders. It leverages a unique platform for the identification and characterization of advanced therapy drug candidates. Its lead program is a drug candidate in clinical development for Batten disease, a rare neurodegenerative disorder.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-07-03 07:30
THERANEXUS, LYON NEUROSCIENCE RESEARCH CENTER AND CERMEP WIN THE '2024 RESEARCH…
English 906.8 KB
2024-07-03 07:30
THERANEXUS, LE CENTRE DE RECHERCHE EN NEUROSCIENCES DE LYON ET LE CERMEP, LAURÉ…
French 852.3 KB
2024-06-06 07:30
Theranexus and BBDF confirm positive 18-month results for Batten-1 in Phase I/I…
English 432.3 KB
2024-06-06 07:30
Theranexus et BBDF confirment les résultats positifs à 18 mois de Batten-1 dans…
French 394.5 KB
2024-05-02 07:30
MISE A DISPOSITION DU DOCUMENT D'ENREGISTREMENT UNIVERSEL 2023
French 281.5 KB
2024-04-30 18:07
URD 2023
French 12.5 MB
2024-04-29 18:20
THERANEXUS PUBLISHES ITS 2023 FULL-YEAR RESULTS AND PRESENTS ITS PROGRESS REPORT
English 383.5 KB
2024-04-29 18:00
THERANEXUS PUBLIE SES RESULTATS ANNUELS 2023 ET FAIT LE POINT SUR SES ACTIVITÉS
French 394.9 KB
2024-04-26 18:00
Information mensuelle relative au nombre total de droits de vote et d'actions c…
French 240.7 KB
2024-04-23 07:30
Theranexus, Diverchim and Inserm awarded EUR 4.7 million in funding under the '…
English 462.7 KB
2024-04-23 07:30
Theranexus, Diverchim et l'INSERM bénéficient d'un financement de 4.7 millions …
French 465.8 KB
2024-04-18 18:00
Theranexus and BBDF announce final and positive safety and efficacy data in the…
English 263.5 KB
2024-04-18 18:00
Theranexus et BBDF annoncent les données finales et positives de sécurité et d'…
French 289.7 KB
2024-02-14 18:00
THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2023 AND PRESENTS AN U…
English 294.1 KB
2024-02-14 18:00
THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 31 DÉCEMBRE 2023 ET FAIT UN POIN…
French 269.5 KB

Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Theranexus

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Theranexus via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.